Skip to content

Trial of Myopia Prevention Using +3D Lenses

A Randomised, Controlled Trial of Prevention of Juvenile-Onset Myopia in Chinese Children

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00627874
Acronym
PLS
Enrollment
1200
Registered
2008-03-04
Start date
2010-04-30
Completion date
2012-04-30
Last updated
2009-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to assess whether a short-term imposed myopic defocus is effective in preventing the development and progression of juvenile-onset myopia in Chinese children.

Detailed description

1. To determine if +3D lenses wearing for half an hour everyday prevents the development and progression of myopia in school children. 2. To identify ocular parameters and risk factors at baseline associated with development and progression of myopia.

Interventions

DEVICE+3D Lenses

wear +3D glasses for 30 minutes per day and engage in activities which require vision at more than 1m

Sponsors

Australian National University
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All children in the selected class are enrolled

Exclusion criteria

* Hyperopia \> +2.0 D * High myopia \> -6.0 D * Astigmatism\> 1.5 D * Anisometropia \> 1.5 D * Strabismus and amblyopia * Any ocular, systemic, or neurodevelopmental conditions that could influence refractive development * Chronic medication use that might affect myopia progression or visual acuity * Already receiving other treatment for progressing myopia

Design outcomes

Primary

MeasureTime frame
Axial Length of eyesAnnual

Secondary

MeasureTime frame
AutorefractionAnnual

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026